CKMT1A and Alzheimer disease: The findings suggested that CAMK4 and CKMT1A were significantly upregulated in the control groups, while ITPKB, GPI, and PCSK2 were remarkably upregulated in the AD groups, consistent with our previous findings (Figures 7M–Q).